Lattice Biologics launched AmnioVisc™, a minimally-processed amniotic fluid supplement for the treatment of osteoarthritis pain in all joints.
Results from a 275-patient study demonstrated lasting pain relief and fewer adverse events than hyaluronic acid viscosupplements, the current standard of care, including single-injection MONOVISC™, 3-injection ORTHOVISC® and Synvisc-One®.
Study highlights indicate:
At 30 days, 75% of AmnioVisc recipients reported pain relief that was >40%
At 90 days, the number of AmnioVisc patients reporting >40% relief increased to nearly 80%
At 180 days, 67% of AmnioVisc patients maintained >40% pain relief
AmnioVisc™ is administered in a single injection regimen and is available for distribution throughout the U.S., Canada and internationally.
Sources: Lattice Biologics, Inc.; ORTHOWORLD Inc.
Lattice Biologics launched AmnioVisc™, a minimally-processed amniotic fluid supplement for the treatment of osteoarthritis pain in all joints.
Results from a 275-patient study demonstrated lasting pain relief and fewer adverse events than hyaluronic acid viscosupplements, the current standard of care, including single-injection...
Lattice Biologics launched AmnioVisc™, a minimally-processed amniotic fluid supplement for the treatment of osteoarthritis pain in all joints.
Results from a 275-patient study demonstrated lasting pain relief and fewer adverse events than hyaluronic acid viscosupplements, the current standard of care, including single-injection MONOVISC™, 3-injection ORTHOVISC® and Synvisc-One®.
Study highlights indicate:
At 30 days, 75% of AmnioVisc recipients reported pain relief that was >40%
At 90 days, the number of AmnioVisc patients reporting >40% relief increased to nearly 80%
At 180 days, 67% of AmnioVisc patients maintained >40% pain relief
AmnioVisc™ is administered in a single injection regimen and is available for distribution throughout the U.S., Canada and internationally.
Sources: Lattice Biologics, Inc.; ORTHOWORLD Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Copy to clipboard 
